Follow
Andrew Menzies-Gow
Andrew Menzies-Gow
Consultant Physician, Royal Brompton Hospital
Verified email at rbht.nhs.uk
Title
Cited by
Cited by
Year
Eosinophil's role remains uncertain as anti–interleukin-5 only partially depletes numbers in asthmatic airway
PT Flood-Page, AN Menzies-Gow, AB Kay, DS Robinson
American journal of respiratory and critical care medicine 167 (2), 199-204, 2003
9542003
Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics
P Flood-Page, A Menzies-Gow, S Phipps, S Ying, A Wangoo, MS Ludwig, ...
The Journal of clinical investigation 112 (7), 1029-1036, 2003
9402003
Tezepelumab in adults and adolescents with severe, uncontrolled asthma
A Menzies-Gow, J Corren, A Bourdin, G Chupp, E Israel, ME Wechsler, ...
New England Journal of Medicine 384 (19), 1800-1809, 2021
5412021
The biology of eosinophils and their role in asthma
CN McBrien, A Menzies-Gow
Frontiers in medicine 4, 93, 2017
3442017
Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult …
J Sweeney, CC Patterson, A Menzies-Gow, RM Niven, AH Mansur, ...
Thorax 71 (4), 339-346, 2016
3312016
Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics
A Menzies-Gow, P Flood-Page, R Sehmi, J Burman, Q Hamid, ...
Journal of Allergy and Clinical Immunology 111 (4), 714-719, 2003
3162003
Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies
JM FitzGerald, ER Bleecker, A Menzies-Gow, JG Zangrilli, I Hirsch, ...
The Lancet Respiratory Medicine 6 (1), 51-64, 2018
2942018
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
D Lefaudeux, B De Meulder, MJ Loza, N Peffer, A Rowe, F Baribaud, ...
Journal of Allergy and Clinical Immunology 139 (6), 1797-1807, 2017
2862017
Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early-and late-phase allergic reactions …
A Menzies-Gow, S Ying, I Sabroe, VL Stubbs, D Soler, TJ Williams, ...
The Journal of Immunology 169 (5), 2712-2718, 2002
2822002
Co‐morbidities in severe asthma: C linical impact and management
C Porsbjerg, A Menzies‐Gow
Respirology 22 (4), 651-661, 2017
2472017
Systematic literature review of systemic corticosteroid use for asthma management
ER Bleecker, AN Menzies-Gow, DB Price, A Bourdin, S Sweet, AL Martin, ...
American journal of respiratory and critical care medicine 201 (3), 276-293, 2020
2232020
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
J Bousquet, A Addis, I Adcock, I Agache, A Agusti, A Alonso, ...
European Respiratory Journal 44 (2), 304-323, 2014
2162014
The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry
S O'Neill, J Sweeney, CC Patterson, A Menzies-Gow, R Niven, ...
Thorax 70 (4), 376-378, 2015
2142015
Characterization of severe asthma worldwide: data from the International Severe Asthma Registry
E Wang, ME Wechsler, TN Tran, LG Heaney, RC Jones, AN Menzies-Gow, ...
Chest 157 (4), 790-804, 2020
2032020
Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma
ER Bleecker, ME Wechsler, JM FitzGerald, A Menzies-Gow, Y Wu, ...
European Respiratory Journal 52 (4), 2018
2012018
Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
LG Heaney, CE Brightling, A Menzies-Gow, M Stevenson, RM Niven, ...
Thorax 65 (9), 787-794, 2010
2012010
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind …
S Diver, L Khalfaoui, C Emson, SE Wenzel, A Menzies-Gow, ME Wechsler, ...
The Lancet Respiratory Medicine 9 (11), 1299-1312, 2021
1792021
Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma
NC Thomson, R Chaudhuri, LG Heaney, C Bucknall, RM Niven, ...
Journal of Allergy and Clinical Immunology 131 (4), 1008-1016, 2013
1722013
An expert consensus framework for asthma remission as a treatment goal
A Menzies-Gow, M Bafadhel, WW Busse, TB Casale, JWH Kocks, ...
Journal of Allergy and Clinical Immunology 145 (3), 757-765, 2020
1682020
Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI
D Gibeon, K Batuwita, M Osmond, LG Heaney, CE Brightling, R Niven, ...
Chest 143 (2), 406-414, 2013
1662013
The system can't perform the operation now. Try again later.
Articles 1–20